Fungal Vascular Graft Infections, French Multicenter Retrospective Study (NCT07143409) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Fungal Vascular Graft Infections, French Multicenter Retrospective Study
France300 participantsStarted 2026-01
Plain-language summary
Fungal vascular graft and endograft infections (VGEIs) are rare but life-threatening infections. Best therapeutic management is unknown. This study retrospectively gathers fungal VGEIs from 12 university hospital centers in France over a 10 year's period in order to describe their epidemiology, clinical features, therapeutic management and outcomes. Focusing on Candida spp. VGEIs, we aim to determine prognosis factors associated with therapeutic management
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged ≥ 18 years old with diagnosis of vascular graft and endograft infections (VGEI) in accordance to MAGIC criteria with diagnosis of proven invasive fungal infection according to EORTC criteria.
* No opposition to re-use data.
Exclusion Criteria:
* Patient previously treated for fungal VGEI
* Patient with suspected VGEI diagnosis based solely on prosthesis implantation in an infected site
* Poor understanding of French.
* Patient under legal protection.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is specifically looking at fungal infections in vascular grafts — does my situation actually involve a confirmed or suspected fungal infection, and is that something my care team is actively investigating?
2Since this is a retrospective study that only looks back at past patient records rather than testing a new treatment, what would my participation actually involve, and would it change anything about how I'm treated day to day?
3The study is tracking mortality rates as its main outcome — what does that tell us about how serious fungal vascular graft infections are, and how does my current prognosis compare to what researchers might be studying here?
4This trial isn't recruiting yet — are there other studies or treatment centers already collecting data on fungal vascular graft infections that might be relevant to my care right now?
5Given that this is a French multicenter study, would being involved require me to share my medical records across institutions, and are there any privacy or logistical concerns I should understand before considering participation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.